Aurinia Pharmaceuticals
AUPH
AUPH
165 hedge funds and large institutions have $637M invested in Aurinia Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 60 increasing their positions, 40 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $678M → $637M (-$40.9M)
20% less call options, than puts
Call options by funds: $34M | Put options by funds: $42.5M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
165
Holding in Top 10
2
Calls
$34M
Puts
$42.5M
Top Buyers
| 1 | +$43M | |
| 2 | +$13.8M | |
| 3 | +$6.78M | |
| 4 |
Jane Street
New York
|
+$3.24M |
| 5 |
SGA
Sector Gamma AS
Oslo,
Norway
|
+$3.04M |
Top Sellers
| 1 | -$23.2M | |
| 2 | -$21.2M | |
| 3 | -$12.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.43M |